Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-02-20

Clinical Trial Update: Mitochondrial Dysfunction Contributes to Sepsis Induced Cardiac Dysfunction

View source ↗

Summary

A University of Alabama at Birmingham trial evaluating mitochondrial dysfunction in sepsis-induced cardiac dysfunction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Sepsis | Status: WITHDRAWN